The journal
Open the journal →The conversation starts in the journal — be the first to post.
About Jane Grogan
Jane L. Grogan is an Australian-born, US-based scientist specializing in immunology and cancer research. In 2009, she was the corresponding author of the paper that first described a novel inhibitory immune receptor that became a drug target in cancer immunotherapy. Grogan is currently the executive vice president and head of research at Biogen.
Everything about Jane Grogan →- Occupation
- academic